Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00984945
What this trial is testing

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 48
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Large-scale testing (Phase 3)Study completedNCT01339312
What this trial is testing

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Who this might be right for
RabiesRabies Virus
Sanofi Pasteur, a Sanofi Company 816
Early research (Phase 1)Study completedNCT01915212
What this trial is testing

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 69
Early research (Phase 1)Study completedNCT00435396
What this trial is testing

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

Who this might be right for
Infections, Cytomegalovirus
GlaxoSmithKline 40
Large-scale testing (Phase 3)UnknownNCT05015686
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 2,400
Early research (Phase 1)Study completedNCT01519817
What this trial is testing

Cancer Vaccine Targeting Brachyury Protein in Tumors

Who this might be right for
NeoplasmsMalignant Solid TumorsColon Neoplasms+1 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Study completedNCT00870649
What this trial is testing

Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium

Who this might be right for
Urinary SchistosomiasisSchistosoma Haematobium
Institut National de la Santé Et de la Recherche Médicale, France 250
Early research (Phase 1)Study completedNCT06485258
What this trial is testing

CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

Who this might be right for
Rotavirus Infections
Centers for Disease Control and Prevention 50
Testing effectiveness (Phase 2)WithdrawnNCT00757926
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Who this might be right for
Rotavirus Infections
Shantha Biotechnics Limited 240
Testing effectiveness (Phase 2)Study completedNCT03503058
What this trial is testing

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

Who this might be right for
Malaria
Sanaria Inc. 345
Not applicableUnknownNCT06303635
What this trial is testing

Safety of UFRJvac, Trivalent COVID-19 Vaccine

Who this might be right for
Healthy People
Azidus Brasil 156
Testing effectiveness (Phase 2)Study completedNCT01262976
What this trial is testing

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Who this might be right for
Tuberculosis
GlaxoSmithKline 240
Early research (Phase 1)Study completedNCT01236040
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 521
Testing effectiveness (Phase 2)WithdrawnNCT00415649
What this trial is testing

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01770743
What this trial is testing

Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

Who this might be right for
Anthrax
Emergent BioSolutions 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909358
What this trial is testing

Solidarity/Tokomeza Ebola Trial

Who this might be right for
Sudan Ebola Virus Vaccines
Makerere University 2,121
Not applicableUnknownNCT03664648
What this trial is testing

DV2-HBV-27: Observational Pregnancy Registry

Who this might be right for
Pregnant
Dynavax Technologies Corporation 300
Testing effectiveness (Phase 2)Study completedNCT02332733
What this trial is testing

Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 266
Testing effectiveness (Phase 2)Study completedNCT00392015
What this trial is testing

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

Who this might be right for
Plasmodium Falciparum
U.S. Army Medical Research and Development Command 59
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation